5 research outputs found
Baseline characteristics for those initiating MDR-TB treatment (N = 61).
<p>N/A =  not applicable.</p>*<p>6 (67%) of HIV positive patients were on antiretroviral therapy prior to referral for MDR-TB treatment.</p>†<p>Forty-eight baseline chest radiographs were available for analysis.</p
Prevalence of medication related symptoms.
<p>The prevalence of medication related symptoms during the inpatient intensive phase occurring at least once in an individual patient, as determined by percentage of total patients (N = 61).</p
Comparison of patients that completed intensive phase of MDR-TB therapy to those that died.
*<p>Excludes 3 patients that defaulted.</p>†<p>Excludes 8 patients for whom follow-up sputum culture results unavailable.</p><p>N/a =  not applicable.</p
Distribution of the time to sputum culture conversion.
<p>Legend: Sputum was collected for culture prior to treatment initiation and monthly thereafter. Culture conversion was defined as the first of two consecutive months of negative cultures. Eight subjects were excluded as regular follow-up culture results were unavailable.</p
Patients referred to KNTH for MDR-TB treatment.
<p>KNTH =  Kibong’oto National TB Hospital, Tanzania. MDR-TB =  multidrug-resistant tuberculosis. All patients had pulmonary TB.</p